Rapid Construction of Green Nanopesticide Delivery Systems Using Sophorolipids as Surfactants by Flash Nanoprecipitation

Green delivery carriers of nanopesticides, like sophorolipid biosurfactants, are of great significance to reduce environmental pollution and promote sustainable agricultural development. However, the molecular diversity of an unisolated sophorolipid mixture with almost unpredictable self-assembly properties has limited the in-depth study of its structure-activity relationship and hindered the development of green pesticide delivery systems. In this work, the acidic and lactonic sophorolipids were successfully separated from the sophorolipid mixture through silica gel column chromatography. A series of cost-effective green nanopesticides loaded with lambda-cyhalothrin (LC) were rapidly fabricated based on a combination of the acidic and lactonic sophorolipids as surfactants by flash nanoprecipitation. The effects of the acidic-to-lactonic ratio on particle size, drug loading capacity, and biological activity against Hyphantria cunea of LC-loaded nanoparticles were systematically investigated. The resultant nanopesticides exhibited a better insecticidal efficacy than a commercial emulsifiable concentrate formulation. This work opens up a novel strategy to construct scalable, cost-effective, and environmentally friendly nanopesticide systems.

Silicon Tetrapyrazinoporphyrazine Derivatives-Incorporated Carbohydrate-Based Block Copolymer Micelles for Photodynamic Therapy

Developing nonaggregated photosensitizers (PSs) for efficient photodynamic therapy (PDT) using polymeric micelles (PMs) has been challenging. In this study, axially substituted nonaggregated silicon tetrapyrazinoporphyrazine (SiTPyzPz) derivatives in carbohydrate-based block glycopolymer-based PMs were designed and used as PSs for PDT. To achieve the nonaggregated PSs, SiTPyzPz was axially substituted with trihexylsiloxy (THS) groups to form SiTPyzPz-THS, which exhibited highly monomeric behaviors in organic solvents. Moreover, three block copolymers were prepared via reversible addition-fragmentation chain transfer (RAFT) polymerization. Each copolymer comprised hydrophobic polystyrene blocks and loadable SiTPyzPz-THS, and one or two consisted of two possible hydrophilic blocks, polyethylene glycol or poly(glucosylethyl methacrylate). The self-assembly of SiTPyzPz-THS and the block copolymers in aqueous solvents induced the formation of spherical PMs with core-shell or core-shell-corona structures. The SiTPyzPz-THS in the PMs exhibited monomeric state, intense fluorescence emission, and outstanding singlet oxygen generation; moreover, it did not form aggregates. During the in vitro test, which was performed to investigate the PDT efficiency, the PMs, which consisted of poly(glucosylethyl methacrylate) shells, exhibited high photocytotoxicity and cellular internalization ability. Consequently, the PM systems of nonaggregated PSs and carbohydrate-based block copolymers could become very promising materials for PDT owing to their photophysicochemical properties and considerable selectivity against cancer cells.

Preparation and application of a polymer with pH/temperature-responsive targeting

Targeted drug carrier systems not only prolong the long-term circulation of drugs, but also improve their bioavailability. To obtain a pH/temperature synergistically responsive polymer carrier, temperature and pH-sensitive groups were chemically grafted onto a cassava starch backbone. Secondly, the structure of the polymer micelle carrier was characterized, and finally the drug loading performance and capacity of the drug carrier were explored. It was observed that cumulative drug release was low when the temperature and pH values met one of two conditions. Only at a high temperature and low pH (T = 38 °C, pH = 5.5, as in tumor tissue) did cumulative drug release reach its maximum value. The design of the polymer carrier described in the present study represents a novel paradigm in precision release drug carriers.

Nanoformulations of doxorubicin: how far have we come and where do we go from here?

Nanotechnology, focused on discovery and development of new pharmaceutical products is known as nanopharmacology, and one research area this branch is engaged in are nanopharmaceuticals. The importance of being nano has been particularly emphasized in scientific areas dealing with nanomedicine and nanopharmaceuticals. Nanopharmaceuticals, their routes of administration, obstacles and solutions concerning their improved application and enhanced efficacy have been briefly yet comprehensively described. Cancer is one of the leading causes of death worldwide and evergrowing number of scientific research on the topic only confirms that the needs have not been completed yet and that there is a wide platform for improvement. This is undoubtedly true for nanoformulations of an anticancer drug doxorubicin, where various nanocarrriers were given an important role to reduce the drug toxicity, while the efficacy of the drug was supposed to be retained or preferably enhanced. Therefore, we present an interdisciplinary comprehensive overview of interdisciplinary nature on nanopharmaceuticals based on doxorubicin and its nanoformulations with valuable information concerning trends, obstacles and prospective of nanopharmaceuticals development, mode of activity of sole drug doxorubicin and its nanoformulations based on different nanocarriers, their brief descriptions of biological activity through assessing in vitro and in vivo behavior.

Synthesis and pH-responsive self-assembly behavior of a fluorescent amphiphilic triblock copolymer mPEG-b-PCL-b-PDMAEMA-g-PC for the controlled intracellular delivery of doxorubicin

Schematic illustration of the pH-responsive self-assembly of a mPEG-b-PCL-b-PDMAEMA-g-PC copolymer with fluorescent coumarin units for controlling DOX release.